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OF THE opportunistic infections reported in renal transplant patients, tuberculosis has been infre-
quently encountered, although its incidence is higher in 
this group than in the general population. I- 3 In our own 
program, sporadic cases have occurred at the rate of one 
or two per year. Beginning in October 1990, however, an 
epidemic of seven cases of tuberculosis was seen with one 
additional sporadic case. We studied its etiology and 
epidemiology, and implemented a program of isoniazid 
prophylaxis to stop the outbreak. 
THE CASES 
A summary of the cases is given in Table 1. The index case 
(patient 1) in this series was infected while visiting his 
mother in an outlying hospital, where another patient with 
tuberculosis was hospitalized. The diagnosis in this other 
patient was not established until autopsy; 19 of 29 nurses 
caring for this patient became PPD positive. The index 
case was admitted at the end of September 1990 to our 
hospital, with chest pain and a normal chest x-ray. It was 
2 weeks before radiographic abnormalities developed, and 
a diagnosis was made on bronchoalveolar lavage. As is the 
usual protocol, this case was reported to the hospital 
Infection Control Committee and the County Health De-
partment. 
The next 4 cases all presented in December 1990, in 
rapid succession. One patient was diagnosed and treated in 
an outlying hospital; the others were treated in our hospi-
tal. They presented with fevers, night sweats, and pUlmo-
nary infiltrates, and were diagnosed either by sputum 
stains for acid-fast organisms or by bronchoalveoalar lav-
age. The two additional cases were diagnosed in January 
and March of 1991. 
In January 1991, all renal transplant patients who might 
have been exposed were started on prophylactic isoniazid 
(IN H) 300 mg/d, and pyridoxine 50 mg/d. Thereafter, the 
only new case that developed, ie, the one in March 1991, 
was in a patient who had been noncompliant with her INH 
prophylaxis. 
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Table 1. Cases of Tuberculosis in Renal Transplant Recipients 
TB Time Rejection Treat-
Patient Age! AfterTx Presenting Pos. Culture ments Prior to 
No. Sex/Race (Months) CXR Symptoms Sites Other Infections TB Outcome 
33/M/C 5 RUL Chest pain BAL, BM Staph epid. bacteremia 1 9 SM Recovered with preserved 
renal function 
2 41/M/B 1.5 LUL Fever BAL CMV pneumonia 0 Recovered with graft loss 
due to rejection 
3 36/F/C 6.5 RUL Fever BAL 0 Recovered with preserved 
renal function 
4 20/F/C 1.5 RML Fever, BAL CMV pneumonia 3 9 SM, 50 mg Died from infection 
cough OKT3 
5 65/F/C 5 Lin LLL Dehydration, BAL CMV pneumonia 1.5 9 SM Died from infection 
lethargia 
6 59/F/C 4.5 RUL Fever BAL Klebsiella pyelonephritis, 1 9 SM Died from infection 
CMV pneumonia 
7 43/F/C 9 Interstitial Fever SAL CMV pnuemonia 49 SM Graft loss due to rejection 
infiltrate prior to tb diagnosis. Re-
covered from infection, 
Died from seizures on 
dialysis 
8 28/F/C 6.5 LUL Tonsillitis Tonsil, cervi- 1 9 SM Recovered with preserved 
cal lymph renal function 
node, spu-
tum 
Abbreviations: M: male, F: female, B: black, C: caucasian, TB: tuberculosiS. RUl: right upper lobe infiltrate, lUL: left upper lobe infiltrate. lll: left lower lobe infiltrate, 
Lin: lingula infiltrate, BAl: bronchoalveolar lavage, BM: bone marrow, SM: solumedroi. 
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Upon further investigation, we discovered that all seven 
patients had been on the same hallway of the same floor at 
some time in October 1990, before the diagnosis was 
established in the index case. DNA analysis of the organ-
ism4 revealed that all cases had the same strain of Myco-
bacterium tuberculosis, which was sensitive to all antitu-
berculous agents. Ventilatory studies of the floor revealed 
a relatively stagnant airflow, with two rooms actually 
having a positive pressure airflow from the room to the 
hallway. The sporadic case presented with a tonsillar 
abscess and scrofula; she was diagnosed by a lymph node 
aspiration and examination of the tonsillectomy specimen. 
She had been away from Pittsburgh throughout this time, 
and was thought not to be part of the epidemic. 
After the diagnosis of tuberculosis was made, antituber-
culous therapy with three to five agents was started. The 
immunosuppression was either stopped or markedly re-
duced. 
Three patients died as a result of infection, all of whom 
also had infection with organisms other than M. tubercu-
losis. Another patient, who had lost her allograft to rejec-
tion prior to the diagnosis of tuberculosis, died from a 
dialysis complication. One patient survived with the loss of 
the allograft to rejection, whereas three patients, including 
the index case, survived with a functioning allograft. 
All eight patients had received FK 506 for immunosup-
pression after renal transplantation. Of the 42 renal trans-
plant patients who were at highest risk, ie, who had been 
on the same floor with the index case in October 1990, only 
one had been on cyclosporine (CyA) instead of FK 506. 
DISCUSSION 
Over 140 cases of tuberculosis in renal transplant recipi-
ents have been reported. Most published series are small, 
and the reported success of treatment is variable, with the 
reported mortality rate ranging from 0% to 100%.1-7 How-
ever, a recent review of all the cases in the literature, 
found that the mortality from tuberculosis infection was 
20%; another 10% of these cases died from other compli-
cations. 1 These represent the first cases of mycobacterial 
infections in patients treated with FK 506. The mortality 
from tuberculosis in this series. 37.5%, appears to be 
comparable to the experience in the literature with con-
ventional immunosuppression. 
Simultaneous infections with cytomegalovirus and/or 
various bacterial pathogens occurred in six of our eight 
cases; these simultaneous opportunistic infections proba-
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bly contributed to the morbidity and mortality in this 
material. The combination of cytomegalovirus and tuber-
culosis was especially lethal-four of the five patients 
requiring antituberculous therapy and gancyclovir ulti-
mately died. 
Ordinarily, nosocomial transmission of opportunistic 
infections in immunosuppressed patients is uncommon, 
and this epidemic was unprecedented in our experience. 
We think that it is unlikely that the mere fact of FK 506 
immunosuppression played a role here. Our speculation is 
that the unusual infectivity of this organism (as seen in the 
high conversion rate among the nurses in the outlying 
hospital) combined with the ventilatory airflow pattern on 
the floor to cause this outbreak. At present, all transplant 
patients admitted to the hospital with a question of a 
pulmonary problem are placed on respiratory isolation 
until three sputa are found to be AFB negative. 
Prophylaxis with isoniazid has been shown to prevent 
the reactivation of tuberculosis in immunosuppressed pa-
tients, I and it has been used previously in our PPD-
positive recipients. In this situation, widespread use of 
prophylactic isoniazid was effective in terminating the 
epidemic. Hepatotoxicity was monitored with routine liver 
function screening, and no cases of serious hepatotoxicity 
developed. 
This report serves to underscore the seriousness of 
tuberculosis in renal transplant patients, during a time 
when the overall incidence of tuberculosis is increasing,8 
as well as the need to diagnose. isolate, and treat this 
disease as soon as it is suspected. In addition, widespread 
prophylaxis with isoniazid may be necessary to prevent 
nosocomial spread. 
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